The short interest data are out for the March 13 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or break them. A single failed clinical trial can mean disaster for a stock. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
Source: Thinkstock
The March 13 short interest data have been compared with the end of February figures, and the short interest, or sentiment on the industry, has remained relatively the same.
Amgen Inc. (NASDAQ: AMGN) saw its short interest remain relatively flat at 10.2 million shares, with 3.6 days to cover. The previous short interest reading was 10.3 million with 3.1 days to cover. The short interest for Amgen has been rising past its dip to its lowest levels. Shares closed Tuesday at $166.01, in a 52-week trading range of $108.20 to $173.14.
Biogen Idec Inc. (NASDAQ: BIIB) saw its short interest increase slightly to 3.6 million, with 2.4 days to cover, from the previous level of 3.4 million shares with 3.2 days to cover. Shares closed Tuesday at $452.63, within a 52-week trading range of $272.02 to $480.18.
ALSO READ: The Most Shorted Nasdaq Stocks in March
Celgene Corp. (NASDAQ: CELG) saw a short interest fall only slightly for this settlement date, to 14.5 million shares with 3.5 days to cover. The level for the previous settlement date was 12.8 million with 2.7 days to cover. Shares of Celgene closed Tuesday at $122.15, in a 52-week trading range of $66.85 to $125.45.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest fall to 56.0 million with 6.3 days to cover, from 56.2 million with 6.7 days to cover. Investors seem to have backed off shorting this stock in September, when shares were poised to hit 52-week highs, but it is looking like the short interest is starting to pile back on at these raised levels. Shares closed Tuesday at $101.41, in a 52-week trading range of $63.50 to $116.83.
Mannkind Corp. (NASDAQ: MNKD) remained flat in terms of its short interest at 90.9 million shares, with 13.0 days to cover. The previous reading was 90.7 million, with 17.0 days to cover. The current short interest reading for Mannkind is the 52-week high by roughly 4 million. Shares closed Tuesday at $5.25. The 52-week trading range is $3.80 to $11.48.
Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) short interest increased to 3.3 million shares with 3.1 days to cover, up from the previous level of 3.2 million with 3.7 days to cover. There has been a trend since mid-November wherein the short interest has had some of the lowest readings for the past 52 weeks. Shares closed Tuesday at $183.44, in a 52-week trading range of $136.37 to $203.30.
ALSO READ: The 5 Most Shorted NYSE Stocks in March
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
